| Serial Number | 99227782 |
| Word Mark | PRIMER REPRO |
| Filing Date | Tuesday, June 10, 2025 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Friday, January 2, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Veterinary apparatus and instruments, namely, intra-vaginal apparatus for animals, namely, vaginal dilators and vaginal syringes; veterinary and medical devices for slow hormone release, namely, dosage dispensers |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 10, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | UNIÃO QUÍMICA FARMACÊUTICA NACIONAL S.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Embu-Guaçu, SP 05676 BR |
| Event Date | Event Description |
| Tuesday, June 10, 2025 | NEW APPLICATION ENTERED |
| Tuesday, June 10, 2025 | APPLICATION FILING RECEIPT MAILED |
| Sunday, October 12, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 30, 2025 | ASSIGNED TO EXAMINER |
| Thursday, October 30, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, October 30, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, October 30, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 12, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 12, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 12, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 2, 2026 | FINAL REFUSAL WRITTEN |
| Friday, January 2, 2026 | FINAL REFUSAL E-MAILED |
| Friday, January 2, 2026 | NOTIFICATION OF FINAL REFUSAL EMAILED |